TOP TIERMARKET NEWSWIRE
News & sentiment

AGOMAB THERAPEUTICS ADR (AGMB) — News & AI sentiment

AGOMAB THERAPEUTICS ADR (AGMB) news roundup. 1 story in the last 24 hours, 2 in the past week, 3 over 30 days. Average 24-hour sentiment is 48/100 — neutral (50 is neutral). No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 48/100
7d stories
2
avg sentiment 52/100
30d stories
3
avg sentiment 55/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on AGMB

AgomAb Therapeutics NV reports 1H results
Seeking Alpha48 · neutralearnings
15h ago
1d ago
B.Riley initiates Agomab Therapeutics stock with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
Jul 23
Jul 2
Jun 23
Jun 23
Jun 23
AgomAb Therapeutics: High Risk, High Reward Stock
Seeking Alpha65 · bullishanalyst
Jun 4
May 27
Open AGMB in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →